MacroGenics to Participate in Upcoming Investor Conferences
February 26 2021 - 7:30AM
MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
focused on developing and commercializing innovative monoclonal
antibody-based therapeutics for the treatment of cancer, today
announced that the Company's management will participate in the
following investor conferences in March:
- Cowen 41st Annual Health Care Conference.
MacroGenics’ management will participate in the Breast Cancer Panel
on Tuesday, March 2, 2021 at 2:10 pm ET live via webcast to
conference attendees (not available for replay). Management will
also participate in one-on-one meetings.
- H.C. Wainwright & Co. Global Life Sciences
Conference. MacroGenics’ management is scheduled to
participate in one-on-one meetings on Tuesday, March 9, 2021.
In addition, a corporate overview provided by MacroGenics’
management will be available for on-demand viewing March 9-10,
2021.
- Barclays Global Healthcare Conference.
MacroGenics’ management is scheduled to participate in one-on-one
meetings and provide a corporate overview on Thursday, March 11,
2021 at 3:45 pm ET.
Webcasts of the above presentations may be accessed under
"Events & Presentations" in the Investor Relations section
of MacroGenics' website at
http://ir.macrogenics.com/events.cfm. The Company will maintain
archived replays of these webcasts on its website for 30 days after
each conference.
About MacroGenics, Inc.MacroGenics is a
biopharmaceutical company focused on developing and commercializing
innovative monoclonal antibody-based therapeutics for the treatment
of cancer. The Company generates its pipeline of product candidates
primarily from its proprietary suite of next-generation
antibody-based technology platforms, which have applicability
across broad therapeutic domains. The combination of MacroGenics'
technology platforms and protein engineering expertise has allowed
the Company to generate promising product candidates and enter into
several strategic collaborations with global pharmaceutical and
biotechnology companies. For more information, please see the
Company's website at www.macrogenics.com. MacroGenics and the
MacroGenics logo are trademarks or registered trademarks of
MacroGenics, Inc.
###
CONTACT:
Jim Karrels, Senior Vice President, CFO
MacroGenics, Inc.
1-301-251-5172, info@macrogenics.com
MacroGenics (NASDAQ:MGNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
MacroGenics (NASDAQ:MGNX)
Historical Stock Chart
From Apr 2023 to Apr 2024
